Rheumatoid arthritis patients on persistent moderate disease activity on biologics have adverse 5-year outcome compared to persistent low-remission status and represent a heterogeneous group

BACKGROUND: The long-term outcome of rheumatoid arthritis (RA) patients who in clinical practice exhibit persistent moderate disease activity (pMDA) despite treatment with biologics has not been adequately studied. Herein, we analyzed the 5-year outcome of the pMDA group and assessed for within-grou...

Descripción completa

Detalles Bibliográficos
Autores principales: Genitsaridi, Irini, Flouri, Irini, Plexousakis, Dimitris, Marias, Konstantinos, Boki, Kyriaki, Skopouli, Fotini, Drosos, Alexandros, Bertsias, George, Boumpas, Dimitrios, Sidiropoulos, Prodromos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523072/
https://www.ncbi.nlm.nih.gov/pubmed/32993800
http://dx.doi.org/10.1186/s13075-020-02313-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523072/
https://www.ncbi.nlm.nih.gov/pubmed/32993800
http://dx.doi.org/10.1186/s13075-020-02313-w

Ejemplares similares